The role of oxidative post-translational modifications in type 1 diabetes pathogenesis

被引:0
作者
Alhamar, Ghadeer [1 ]
Vinci, Chiara [2 ]
Franzese, Valentina [3 ,4 ,5 ]
Tramontana, Flavia [5 ]
Le Goux, Nelig [6 ]
Ludvigsson, Johnny [7 ]
Nissim, Ahuva [6 ]
Strollo, Rocky [3 ,4 ]
机构
[1] Dasman Diabet Inst, Dept Immunol & Microbiol, Dasman, Kuwait
[2] Univ Libre Bruxelles, Ctr Diabet Res, Brussels, Belgium
[3] San Raffaele Open Univ, Dept Promot Human Sci & Qual Life, Rome, Italy
[4] Fdn Policlin Univ Campus Biomed Roma, Dept Med, Rome, Italy
[5] Univ Campus Biomed Roma, Dept Med, Rome, Italy
[6] Queen Mary Univ London, William Harvey Res Inst, Biochem Pharmacol, London, England
[7] Linkoping Univ, Crown Princess Victor Childrens Hosp, Dept Biomed & Clin Sci, Div Pediat, Linkoping, Sweden
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷
关键词
post-translational modifications; type; 1; diabetes; oxidative stress; neoepitopes; autoimmunity; insulin; autoantibodies; t cell; FREE AMINO-ACIDS; MODIFIED INSULIN; BETA-CELL; ANTIGENIC DETERMINANTS; PROTEIN CARBAMYLATION; BIOLOGICAL-ACTIVITY; MODIFIED GAD65; II COLLAGEN; T-CELLS; DAMAGE;
D O I
10.3389/fimmu.2025.1537405
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of type 1 diabetes (T1D) involves a complex interplay of genetic predisposition, immune processes, and environmental factors, leading to the selective destruction of pancreatic beta-cells by the immune system. Emerging evidence suggests that intrinsic beta-cell factors, including oxidative stress and post-translational modifications (PTM) of beta-cell antigens, may also contribute to their immunogenicity, shedding new light on the multifaceted pathogenesis of T1D. Over the past 30 years, neoepitopes generated by PTMs have been hypothesized to play a role in T1D pathogenesis, but their involvement has only been systematically investigated in recent years. In this review, we explored the interplay between oxidative PTMs, neoepitopes, and T1D, highlighting oxidative stress as a pivotal factor in immune system dysfunction, beta-cell vulnerability, and disease onset.
引用
收藏
页数:13
相关论文
共 138 条
  • [91] Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders
    Ramazi, Shahin
    Allahverdi, Abdollah
    Zahiri, Javad
    [J]. JOURNAL OF BIOSCIENCES, 2020, 45 (01)
  • [92] Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
    Ramos, Eleanor L.
    Dayan, Colin M.
    Chatenoud, Lucienne
    Sumnik, Zdenek
    Simmons, Kimber M.
    Szypowska, Agnieszka
    Gitelman, Stephen E.
    Knecht, Laura A.
    Niemoeller, Elisabeth
    Tian, Wei
    Herold, Kevan C.
    PROTECT Study Investigators
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23) : 2151 - 2161
  • [93] Insulin Polymers in the Plasma of Obese Subjects Are Associated with Elevated Levels of Carbonyl Groups and Are Decreased by (-)-Epicatechin
    Rincon Viquez, M. J.
    Garcia-Sanchez, J. R.
    Tapia Gonzalez, M. A.
    Gutierrez Lopez, L.
    Ceballos-Reyes, G. M.
    Olivares-Corichi, I. M.
    [J]. HORMONE AND METABOLIC RESEARCH, 2014, 46 (07) : 499 - 504
  • [94] Autoantibodies to post- translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2
    Rizzo, Paola
    Pitocco, Dario
    Zaccardi, Francesco
    Di Stasio, Enrico
    Strollo, Rocky
    Rizzi, Alessandro
    Scavone, Giuseppe
    Costantini, Federica
    Galli, Marco
    Tinelli, Giovanni
    Flex, Andrea
    Caputo, Salvatore
    Pozzilli, Paolo
    Landolfi, Raffaele
    Ghirlanda, Giovanni
    Nissim, Ahuva
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (02)
  • [95] Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
    Rodriguez-Calvo, Teresa
    Johnson, James D.
    Overbergh, Lut
    Dunne, Jessica L.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [96] Increase in Pancreatic Proinsulin and Preservation of -Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset
    Rodriguez-Calvo, Teresa
    Zapardiel-Gonzalo, Jose
    Amirian, Natalie
    Castillo, Ericka
    Lajevardi, Yasaman
    Krogvold, Lars
    Dahl-Jorgensen, Knut
    von Herrath, Matthias G.
    [J]. DIABETES, 2017, 66 (05) : 1334 - 1345
  • [97] Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
    Roep, Bart O.
    Thomaidou, Sofia
    van Tienhoven, Rene
    Zaldumbide, Arnaud
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (03) : 150 - 161
  • [98] Antigen Targets of Type 1 Diabetes Autoimmunity
    Roep, Bart O.
    Peakman, Mark
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (04):
  • [99] The Charcot Foot in Diabetes
    Rogers, Lee C.
    Frykberg, Robert G.
    Armstrong, David G.
    Boulton, Andrew J. M.
    Edmonds, Michael
    Ha Van, Georges
    Hartemann, Agnes
    Game, Frances
    Jefecoate, William
    Jirkovska, Alexandra
    Jude, Edward
    Morbach, Stephan
    Morrison, William B.
    Pinzur, Michael
    Pitocco, Dario
    Sanders, Lee
    Wukich, Dane K.
    Uccioli, Luigi
    [J]. DIABETES CARE, 2011, 34 (09) : 2123 - 2129
  • [100] Activation of PAD4 in NET formation
    Rohrbach, Amanda S.
    Slade, Daniel J.
    Thompson, Paul R.
    Mowen, Kerri A.
    [J]. FRONTIERS IN IMMUNOLOGY, 2012, 3